Topic

North Carolina

A collection of 524 issues

How to Get Vimizim (Elosulfase Alfa) Covered by Humana in North Carolina: Prior Authorization, Appeals, and Medical Necessity Requirements

Answer Box: Your Fastest Path to Approval Humana requires prior authorization for Vimizim (elosulfase alfa) in North Carolina with strict medical necessity criteria. You'll need: confirmed MPS IVA diagnosis via GALNS enzyme testing and genetic analysis, prescription from a metabolic specialist, baseline functional assessments (6-minute walk test, pulmonary
5 min read

Renewing Filspari (Sparsentan) Coverage with Blue Cross Blue Shield in North Carolina: Complete 2024 Guide with Timelines and Forms

Quick Answer: Renewing Filspari Coverage in North Carolina To renew Filspari (sparsentan) coverage with Blue Cross Blue Shield of North Carolina, submit your renewal request 30-45 days before your current approval expires. You'll need updated quarterly liver function tests (ALT/AST), REMS program compliance documentation, nephrology notes showing
6 min read

Do You Qualify for Tavneos (Avacopan) Coverage by Blue Cross Blue Shield in North Carolina? Complete Decision Tree & Appeal Guide

Answer Box: Quick Qualification Check To qualify for Tavneos (avacopan) coverage by Blue Cross Blue Shield in North Carolina, you need: (1) confirmed severe active ANCA-associated vasculitis (GPA or MPA) with positive ANCA serology, (2) prescription from a rheumatologist, nephrologist, or pulmonologist, and (3) use as adjunctive therapy with standard
6 min read

How to Get Gilenya (Fingolimod) Covered by Aetna CVS Health in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Gilenya (Fingolimod) Covered by Aetna CVS Health in North Carolina Aetna requires prior authorization for Gilenya (fingolimod) with approval valid for 12 months. Your neurologist must submit documentation including MS diagnosis (ICD-10 G35), baseline EKG, ophthalmology exam, vaccination records, and prior therapy history. Submit requests at least
6 min read

Work With Your Doctor to Get Vanflyta (Quizartinib) Approved by Blue Cross Blue Shield in North Carolina: Provider Collaboration Guide

Answer Box: Your Path to Vanflyta Approval in North Carolina Getting Vanflyta (quizartinib) covered by Blue Cross Blue Shield of North Carolina requires strong provider collaboration and documentation. Start by confirming your FLT3-ITD mutation test results with your hematologist/oncologist, then work together to submit a comprehensive prior authorization request
6 min read